Media
Press Releases
January 23, 2024
Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP
January 18, 2024
Lupin Receives Approval from U.S. FDA for Febuxostat Tablets
January 14, 2024
Lupin Receives Approval from U.S. FDA for Propranolol Hydrochloride Extended-Release Capsules USP
January 10, 2024
Lupin Launches Varenicline Tablets in the United States
January 9, 2024
Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in the United States
January 4, 2024
Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
CloseSearch Product